Although there are no highly specific markers that can be used to distinguish HCC cells from LCSCs at this stage, many studies have reported that the differential expression of EpCAM (CD326), CD90, CD44 and CD133 could reflect the difference between LCSCs and HCC cells [16, 17, 18, 19, 20]. This evidence concerns the gene CD44 and hepatocellular carcinoma.